Novartis Resumes Production, Delivery Of Radioligand Therapy Medicines

  • Novartis AG NVS said that in early June, it restarted radioligand therapy (RLT) production at its sites in Ivrea, Italy, and Millburn, New Jersey.
  • It also resumed delivering doses to patients in a phased approach, ahead of the expected six-week timeframe. 
  • The company has remediated the issues that led to a temporary, voluntary suspension of production in May. These issues did not affect patient safety, and no risk to patients from the doses previously produced at these sites was identified.
  • Novartis has also restarted screening and enrollment for trials with 177Lu-PSMA-617 and trials with Lutathera in the U.S. and Canada.
  • In addition, Novartis is investing in expanding RLT production capabilities in Millburn and Ivrea and building a new radioligand manufacturing facility in Indianapolis, Indiana, that will be operational in 2023.
  • Price Action: NVS shares are down 0.97% at $83.95 during the premarket session on the last check Thursday.

Posted In: BriefsBiotechLarge CapNewsHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.